CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting
April 23, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
Palmetto MolDx Issues Foundational Coverage for Molecular Testing in Solid Organ Allograft Rejection
April 22, 2021 11:38 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx to Debut Multicenter Data on AlloSure® Lung, an Analytically and Clinically Validated Biomarker of Graft Injury for Lung Transplant Patients
April 22, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx to Report First Quarter 2021 Financial Results
April 21, 2021 16:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021
April 20, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx to Present at UNOS Transplant Management Forum
April 16, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Announces New HLA Typing Service Offering for Research Purposes
April 08, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of...
CareDx to Participate in National Kidney Foundation 2021 Spring Clinical Meetings
April 05, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Enhances Leadership Team with Key Appointments
March 31, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Supports Vir Biotechnology’s Clinical Trial Recruitment Efforts for COMET-ICE
March 23, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...